Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 21, 2022 13:00 ET | Source: DelveInsight Business Research LLP

Toll-Like Receptor Agonist Pipeline Insights | Research Report 2022 by DelveInsight

Las Vegas, USA, Feb. 21, 2022 (GLOBE NEWSWIRE) -- Toll-Like Receptor Agonist Pipeline Insights | Research Report 2022 by DelveInsight Toll-Like Receptor Agonist Pipeline constitutes 45+ key...
May 12, 2011 13:00 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma's Ampligen(R) Cited at Barcelona Vaccine & Active Immunotherapeutics Forum 2011

PHILADELPHIA, May 12, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company" or "Hemispherx") today announced that Ampligen® will be featured in a discussion of...